Hexafluronium bromide
(Redirected from Mylaxen)
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.697 |
Chemical and physical data | |
Formula | C36H42Br2N2 |
Molar mass | 662.554 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Hexafluronium (or hexafluorenium) is a muscle relaxant.[1] It acts as a nicotinic acetylcholine receptor antagonist.
References
- ^ Baraka A (August 1975). "Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase". British Journal of Anaesthesia. 47 (8): 885–8. doi:10.1093/bja/47.8.885. PMID 1201167.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed CASNo identifier
- ECHA InfoCard ID from Wikidata
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Muscle relaxants
- Bromides
- Nicotinic antagonists
- Quaternary ammonium compounds
- Fluorenes
- All stub articles
- Musculoskeletal system drug stubs